Topic: Big Brain

The hosts expand on the ketamine study to discuss the broader implications of the placebo effect in modern medicine. They argue that many psychiatric drugs, such as Zoloft and Xanax, may rely on the patient's belief in the medication rather than chemical efficacy. The segment emphasizes that the placebo effect has real biological foundations and should be considered a valid medical tool.

A major study has challenged the long-held theory that depression is caused by a chemical imbalance in the brain, specifically serotonin levels. Reports suggest that for 85% of users, antidepressants may be no more effective than a placebo. Media outlets have begun framing the questioning of SSRI efficacy as a "right-wing" political attack.

Antony Blinken reports a significant brain drain from Russia, claiming 200,000 educated professionals have fled the country since the invasion began. The departure of international companies like McDonald's is cited as a factor in the declining Russian standard of living. Skepticism is raised regarding the effectiveness of Western weapons like Javelin missiles and the extent of U.S. involvement in managing Ukrainian military supply chains.

The hosts sign off, noting the late arrival of the "Zephyr" and the lack of a presidential notification. The show concludes with a soundbite mix featuring Trump's "big brain" comments, the "one beer" rally routine, and various clips from the Kavanaugh hearings.

Executive Producer Glenn Morphus contributes $338.38 and shares a personal note about his sister's recovery from a brain aneurysm. He also promotes his family startup, Big Brain Place, which sells puzzles, aromatherapy, and sensory blankets designed to improve cognitive health.